
GMP Formulations Private Limited
About GMP Formulations Private Limited
Data last updated:
GMP Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2018PTC122276. Its GSTIN is 36AAHCG1824A1Z4 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹59.1 Lakh. It is led by directors including Shaik Janimiya (Managing Director) and Javeed Shaik (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Crescent Towers 4 – 7 – 11/4/B First Floor Raghavendra Ngr Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.68 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹44.35 Lakh (net margin 6.6%) and EBITDA of ₹59.32 Lakh (EBITDA margin 8.9%).
The company has about 24 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
GMP Formulations Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressCrescent Towers 4 – 7 – 11/4/B First Floor Raghavendra Ngr Nacharam, Hyderabad, Telangana, India – 500076
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of GMP Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of GMP Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of GMP Formulations Private Limited, buy the company report.
Financials of GMP Formulations Private Limited
FY 2025 filings availableGMP Formulations Private Limited reported revenue of ₹6.68 Cr (up 23% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 23% in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GMP Formulations Private Limited, buy the company report.
Board of directors of GMP Formulations Private Limited
GMP Formulations has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Javeed Shaik | Whole-Time Director | 15 Feb 2018 | 8 Years 8 Months | Current |
| Shaik Junaid | Director | 04 May 2023 | 3 Years 5 Months | Current |
| Shaik Janimiya | Managing Director | 15 Feb 2018 | 8 Years 8 Months | Current |
| Shaik Thahera | Whole-Time Director | 15 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
GMP Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tergum Remedies Private Limited | ₹6.74 Cr (FY 2024) | 51.0% | Hyderabad, Telangana, India | |||
| GMP Formulations Private Limitedthis company | ₹6.68 Cr (FY 2024) | ₹44.35 Lakh | 6.6% | 23.0% | 24 | Hyderabad, Telangana, India |
| Aztec Pharma Private Limited | ₹6.65 Cr (FY 2025) | -26.0% | Surendra Nagar, Gujarat, India | |||
| Albios Lifesciences Private Limited | ₹6.63 Cr (FY 2025) | 77.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of GMP Formulations Private Limited, buy the company report.
Auditor
GMP Formulations Private Limited is audited by S.N.M. Nandury & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.N.M. Nandury & Co | FY 2023 | 201040 |
Shareholding
The shareholding of GMP Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of GMP Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving GMP Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GMP Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
GMP Formulations Private Limited has a workforce of 24 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
GMP Formulations has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCG1824A1Z4 | Telangana | Active | 08 Mar 2020 |
| 37AAHCG1824A1Z2 | Andhra Pradesh | Active | 16 Apr 2022 |
To see the full GST registrations and return filing status of GMP Formulations Private Limited, buy the company report.
Recent activity
GMP Formulations Private Limited has 4 board changes on record since 2018: 4 appointments. The latest: Shaik Junaid was appointed as Director on 04 May 2023.
Frequently asked questions
GMP Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 February 2018 (8+ years old) and is registered under CIN U24304TG2018PTC122276.
GMP Formulations has 4 current directors:
- Shaik Janimiya - Managing Director
- Javeed Shaik - Whole-Time Director
- Shaik Thahera - Whole-Time Director
- Shaik Junaid - Director
The latest financial statements of GMP Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of GMP Formulations is 36AAHCG1824A1Z4, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAHCG1824A1Z2 (Andhra Pradesh).
The CIN (Corporate Identification Number) of GMP Formulations is U24304TG2018PTC122276. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GMP Formulations was incorporated on 15 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of GMP Formulations by revenue are Tergum Remedies Private Limited, Aztec Pharma Private Limited, Albios Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Shaik Junaid was appointed as Director on 04 May 2023. Javeed Shaik was appointed as Whole-Time Director on 15 Feb 2018. Shaik Janimiya was appointed as Managing Director on 15 Feb 2018. GMP Formulations has 4 board changes on record in total.
The registered office of GMP Formulations is at Crescent Towers 4 – 7 – 114B First Floor Raghavendra Ngr Nacharam, Hyderabad, Telangana, India – 500076.
GMP Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of GMP Formulations is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.